A. U. Buzdar
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 26
- Cancer Treatment and Pharmacology 16
- HER2/EGFR in Cancer Research 9
- Cancer Diagnosis and Treatment 4
- Cancer Risks and Factors 4
-
- Breast Cancer Treatment Studies 18
- Co-authors
- G. N. Hortobágyi (9 shared papers)Frankie A. Holmes (4 shared papers)D. Frye (4 shared papers)R S Walters (2 shared papers)R. Theriault (2 shared papers)Martin N. Raber (1 shared paper)W. Eiermann (2 shared papers)Anthony Howell (4 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Cancer (5 papers)European Journal of Cancer (4 papers)Annals of Oncology (2 papers)Seminars in Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
A. U. Buzdar
45 papers receiving 2.0k citations
A. U. Buzdar's Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 930
- Oncology 1.2k
- Genetics 422
- Pathology and Forensic Medicine 264
- Radiology, Nuclear Medicine and Imaging 309
Countries citing papers authored by A. U. Buzdar
This map shows the geographic impact of A. U. Buzdar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. U. Buzdar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. U. Buzdar more than expected).
Fields of papers citing papers by A. U. Buzdar
This network shows the impact of papers produced by A. U. Buzdar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. U. Buzdar. The network helps show where A. U. Buzdar may publish in the future.
Co-authors
The 25 scholars most cited alongside A. U. Buzdar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer Hit paper breakdown → | 1991 | 615 |
| 2 | 2007 | 299 | |
| 3 | 1996 | 299 | |
| 4 | Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer. | 1996 | 157 |
| 5 | 2001 | 79 | |
| 6 | 1985 | 66 | |
| 7 | 2009 | 54 | |
| 8 | 2000 | 45 | |
| 9 | 2000 | 41 | |
| 10 | 1997 | 41 | |
| 11 | Recent developments in breast cancer therapy. | 1999 | 37 |
| 12 | 2001 | 30 | |
| 13 | 2004 | 26 | |
| 14 | Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusion. | 1981 | 23 |
| 15 | Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancer. | 1980 | 20 |
| 16 | 2001 | 20 | |
| 17 | 1999 | 19 | |
| 18 | 2005 | 17 | |
| 19 | 2004 | 16 | |
| 20 | 1999 | 14 |
About A. U. Buzdar
A. U. Buzdar is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Dermatology, having authored 46 papers that have together received 2.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (18 papers), Cancer Treatment and Pharmacology (16 papers), Estrogen and related hormone effects (14 papers), HER2/EGFR in Cancer Research (9 papers), Chemotherapy-related skin toxicity (6 papers), Advanced Breast Cancer Therapies (4 papers), Cancer Diagnosis and Treatment (4 papers) and Cancer Risks and Factors (4 papers). The work is most often cited by research in Cancer Research (930 citations), Oncology (1.2k citations), Genetics (422 citations), Pathology and Forensic Medicine (264 citations) and Radiology, Nuclear Medicine and Imaging (309 citations). A. U. Buzdar has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include G. N. Hortobágyi, Frankie A. Holmes, D. Frye, R S Walters, R. Theriault, Martin N. Raber, W. Eiermann, Anthony Howell, W. Jonat and Carl Blomqvist. Their work appears in journals such as Journal of Clinical Oncology, Cancer, European Journal of Cancer, Annals of Oncology and Seminars in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.